![Steven Ryder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Ryder
Direktor/Vorstandsmitglied bei
MBX BIOSCIENCES, INC.
Vermögen: 407 216 $ am 30.06.2026
Profil
Steven W.
Ryder is currently Director at Biotechnology Innovation Organization, Director at Levo Therapeutics, Inc. since 2019, Independent Director at MBX Biosciences, Inc. since 2024, and Chief Medical Officer at Yarrow Bioscience, Inc. starting in 2026.
Former roles include Independent Director at Reata Pharmaceuticals, Inc. from 2022 to 2023, Chief Development Officer at Alexion Pharmaceuticals, Inc. from 2013 to 2018, President at American Society of Clinical Psychopharmacology, President at Astellas Pharma Global Development, Inc. from 2008 to 2013, President-Astellas Pharma Global Development at Astellas Pharma US, Inc. from 2008 to 2013, Chief Medical Officer at Rallybio Corp.
from 2019 to 2026, and Senior VP-Global Research & Development at Pfizer Inc. Education includes a doctorate from Icahn School of Medicine at Mount Sinai.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RALLYBIO CORPORATION 0.48% | 19.12.2025 | 25’451 ( 0.48% ) | 407 216 $ | 30.06.2026 |
| 04.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Steven Ryder
| Unternehmen | Position | Beginn |
|---|---|---|
| MBX BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 01.01.2024 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research into therapeutics | Direktor/Vorstandsmitglied | 01.07.2019 |
Ehemalige bekannte Positionen von Steven Ryder
| Unternehmen | Position | Ende |
|---|---|---|
| RALLYBIO CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 31.03.2026 |
| REATA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 26.09.2023 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.12.2018 |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Präsident | 01.04.2013 |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.04.2013 |
Ausbildung von Steven Ryder
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Psychopharmacology | |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research into therapeutics | Health Technology |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
